Synovial Fluid in Knee Osteoarthritis Extends Proinflammatory Niche for Macrophage Polarization.
Kellgren-Lawrence score
M1/M2 ratio
macrophages
niche
osteoarthritis
synovial fluid
synovitis
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
18 12 2022
18 12 2022
Historique:
received:
27
09
2022
revised:
11
12
2022
accepted:
13
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
Macrophage polarization is a steering factor of osteoarthritis (OA) progression. Synovial fluid (SF) obtained from OA patients with different Kellgren-Lawrence grades (KL grades) holds several proinflammatory factors and was hypothesized to induce macrophage differentiation and polarization by providing the needed microenvironment. U937 cells and peripheral-blood-mononuclear-cell-derived monocytes (PBMC-derived CD14+ cells) were induced with SFs of progressive KL grades for 48 h, and the status of the differentiated cells was evaluated by cell surface markers representing M1 and M2 macrophage phenotypes. Functional viability assessment of the differentiated cells was performed by cytokine estimation. The fraction of macrophages and their phenotypes were estimated by immunophenotyping of SF-isolated cells of different KL grades. A grade-wise proteome analysis of SFs was performed in search of the factors which are influential in macrophage differentiation and polarization. In the assay on U937 cells, induction with SF of KL grade III and IV showed a significant increase in M1 type (CD86+). The percentage of M2 phenotype (CD163+) was significantly higher after the induction with SF of KL grade II. A Significantly higher M1/M2 ratio was estimated in the cells induced with KL grade III and IV. The cell differentiation pattern in the assay on PBMC-derived CD14+ cells showed a grade-wise decline in both M1 (CD11C+, CD86+) and M2 phenotype (CD163+). Cytokine estimation specific to M1 (TNF-α, IL-6, IL-1β, IFN-γ) and M2 (IL-4 and IL-10) macrophages corelated with the differentiation pattern in the U937 cell assay, while it did not reveal any significant changes in the PBMC-derived CD14+ cells assay. SF cells' immunophenotyping showed the highest percentage of CD14+ macrophages in KL grade II; CD86+ and CD163+ cells were minimal in all KL grades' SFs. The proteome analysis revealed significantly expressed MIF, CAPG/MCP, osteopontin, and RAS-related RAB proteins in KL grade III and IV samples, which are linked with macrophages' movement, polarization, and migration-behavior. In conclusion, this study demonstrated that SF in OA joints acts as a niche and facilitates M1 phenotype polarization by providing a proinflammatory microenvironment.
Identifiants
pubmed: 36552878
pii: cells11244115
doi: 10.3390/cells11244115
pmc: PMC9776803
pii:
doi:
Substances chimiques
Proteome
0
Cytokines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Orthop Relat Res. 1992 Jan;(274):294-9
pubmed: 1729015
Mol Cell Proteomics. 2014 Nov;13(11):3138-51
pubmed: 25096996
Semin Arthritis Rheum. 2014 Apr;43(5):579-87
pubmed: 24262930
PLoS One. 2010 Jan 13;5(1):e8668
pubmed: 20084270
Scand J Clin Lab Invest. 2017 Nov;77(7):520-526
pubmed: 28737953
Osteoarthritis Cartilage. 2018 Sep;26(9):1247-1256
pubmed: 29753948
Osteoarthritis Cartilage. 2014 Aug;22(8):1167-75
pubmed: 24911520
Prog Biophys Mol Biol. 2019 Nov;148:4-11
pubmed: 31226307
Joint Bone Spine. 2013 Dec;80(6):568-73
pubmed: 24176735
Arthritis Res Ther. 2019 Jan 18;21(1):26
pubmed: 30658702
Oncol Lett. 2020 Nov;20(5):244
pubmed: 32973957
J Immunol. 2009 Mar 1;182(5):3084-94
pubmed: 19234205
Osteoarthritis Cartilage. 2016 Dec;24(12):2162-2170
pubmed: 27502245
Biochimie. 2019 Jan;156:79-91
pubmed: 30315853
Osteoarthritis Cartilage. 2016 Sep;24(9):1613-21
pubmed: 27084348
Curr Opin Rheumatol. 2008 Sep;20(5):565-72
pubmed: 18698179
Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):84-9
pubmed: 15730927
Immunity. 2016 Apr 19;44(4):755-68
pubmed: 26992565
Osteoporos Int. 2011 Jul;22(7):2175-86
pubmed: 21060993
Adv Clin Chem. 2021;100:37-90
pubmed: 33453867
Int J Biol Sci. 2018 Mar 10;14(4):398-405
pubmed: 29725261
Clin Transl Immunology. 2020 Dec 20;9(12):e1222
pubmed: 33363732
Exp Hematol. 1999 Feb;27(2):353-64
pubmed: 10029175
Eur Cytokine Netw. 2006 Mar;17(1):4-12
pubmed: 16613757
Nat Rev Immunol. 2017 Jul;17(7):451-460
pubmed: 28461703
J Cell Sci. 2003 Jun 15;116(Pt 12):2377-88
pubmed: 12766184
Exp Ther Med. 2018 Dec;16(6):5009-5014
pubmed: 30546406
Genes (Basel). 2021 Jun 29;12(7):
pubmed: 34209473
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Int Orthop. 2009 Jun;33(3):873-7
pubmed: 18350290
Free Radic Biol Med. 2021 May 1;167:81-93
pubmed: 33711419
BBA Clin. 2016 May 12;6:1-4
pubmed: 27331021
Genes Dis. 2020 Jun 27;9(1):128-139
pubmed: 35005113
J Leukoc Biol. 1996 Apr;59(4):555-61
pubmed: 8613704
Immunity. 2020 Mar 17;52(3):434-451
pubmed: 32187515
Biol Reprod. 2016 Feb;94(2):38
pubmed: 26764347
Arch Orthop Trauma Surg. 2019 Sep;139(9):1287-1292
pubmed: 31209613
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94
pubmed: 23641259
Clin Immunol. 2013 Mar;146(3):185-96
pubmed: 23360836
Proteomics. 2021 Aug;21(15):e2100005
pubmed: 34051048
PLoS One. 2014 Feb 03;9(2):e87680
pubmed: 24498352
Immunity. 2013 Mar 21;38(3):570-80
pubmed: 23434060
Oncogene. 2017 Jun 29;36(26):3749-3759
pubmed: 28218903
Arthritis Rheumatol. 2017 Jun;69(6):1221-1232
pubmed: 28141918
J Immunol. 2005 Jul 1;175(1):342-9
pubmed: 15972667
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Cell Mol Life Sci. 2018 Aug;75(15):2873-2886
pubmed: 29441425
Stem Cells Int. 2019 Jan 15;2019:8169172
pubmed: 30766606
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
In Vitro Cell Dev Biol Anim. 2015 Sep;51(8):843-50
pubmed: 26138240
Indian J Pharmacol. 2018 Jan-Feb;50(1):22-29
pubmed: 29861524
Osteoarthritis Cartilage. 2020 May;28(5):639-645
pubmed: 32028022
J Immunol. 2007 Sep 1;179(5):3242-8
pubmed: 17709540
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
J Proteomics. 2010 Jan 3;73(3):602-18
pubmed: 19683082